Literature DB >> 19291091

Differences in clinical manifestations of influenza-associated encephalopathy by age.

Tomoaki Wada1, Tsuneo Morishima, Akihisa Okumura, Masato Tashiro, Mitsuaki Hosoya, Masashi Shiomi, Yoshinobu Okuno.   

Abstract

Data from patients in Japan was analyzed to examine the age distribution and differences by age in the clinical manifestations of influenza-associated encephalopathy. Between 1998 and 2002, 472 cases of influenza-associated encephalopathy in patients aged 15 years or younger were reported to the Collaborative Study Group on Influenza-Associated Encephalopathy. These cases were divided into two groups by age: 0-5 and 6-15 years. The differences between the groups were estimated based on the data for those aged 0-5 years, and the odds ratios and 95% confidence intervals calculated. Distribution was inversely correlated with age, with a peak at 1-2 years old. In comparison with patients aged 0-5, those aged 6-15 years had a significantly greater incidence of type B infection, lower frequency of convulsions, higher frequency of loss of consciousness and altered consciousness as the initial neurological symptom, lower serum transaminase levels, lower frequency of low-density area for brain CT upon admission, and lower incidence of sequelae. Our analysis indicates that the clinical course, laboratory data, and brain imaging findings of influenza-associated encephalopathy exhibits patterns that vary with age.

Entities:  

Mesh:

Year:  2009        PMID: 19291091     DOI: 10.1111/j.1348-0421.2008.00100.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  6 in total

1.  Complex febrile seizures followed by complete recovery in an infant with high-titer 2009 pandemic influenza A (H1N1) virus infection.

Authors:  Mandy F O'Leary; James D Chappell; Charles W Stratton; Robert M Cronin; Mary B Taylor; Yi-Wei Tang
Journal:  J Clin Microbiol       Date:  2010-08-11       Impact factor: 5.948

Review 2.  A Review on Equine Influenza from a Human Influenza Perspective.

Authors:  Fleur Whitlock; Pablo R Murcia; J Richard Newton
Journal:  Viruses       Date:  2022-06-15       Impact factor: 5.818

3.  Characteristics and Outcomes of Influenza-Associated Encephalopathy Cases Among Children and Adults in Japan, 2010-2015.

Authors:  Hideo Okuno; Yuichiro Yahata; Keiko Tanaka-Taya; Satoru Arai; Hiroshi Satoh; Saeko Morino; Tomoe Shimada; Tomimasa Sunagawa; Timothy M Uyeki; Kazunori Oishi
Journal:  Clin Infect Dis       Date:  2018-06-01       Impact factor: 9.079

4.  National surveillance of influenza-associated encephalopathy in Japan over six years, before and during the 2009-2010 influenza pandemic.

Authors:  Yoshiaki Gu; Tomoe Shimada; Yoshinori Yasui; Yuki Tada; Mitsuo Kaku; Nobuhiko Okabe
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

Review 5.  A review of the evidence to support influenza vaccine introduction in countries and areas of WHO's Western Pacific Region.

Authors:  Gina Samaan; Michelle McPherson; Jeffrey Partridge
Journal:  PLoS One       Date:  2013-07-16       Impact factor: 3.240

6.  Characteristics and outcome of influenza-associated encephalopathy/encephalitis among children in a tertiary pediatric hospital in Italy, 2017-2019.

Authors:  Maria Vincenza Mastrolia; Chiara Rubino; Massimo Resti; Sandra Trapani; Luisa Galli
Journal:  BMC Infect Dis       Date:  2019-11-29       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.